Home
About
Innovative Pipeline
Pipeline Overview
Oncology Program
Autoimmune Program
Pioneering Science
Scientific Approach
Translational Medicine
Proprietary Discovery Platform
Publications
Partnering
News
Career
Contact Us
Investors
Elpiscience has raised approximately $260 million and is supported by top-tier healthcare investors.
Our Vision
Advancing immunotherapy to transform lives with the power of science.
Passion
Make everything possible!
Leadership
Let you win!
pleasure
Help you achieve your career!
Our Mission
To develop innovative and transformative immunotherapies that harness the power of the immune system to fight cancer and autoimmune diseases.
Founder
Management Team
Scientific Advisory Board
Darren Ji, MD, Ph.D., MBA
Co-Founder
Hongtao Lu, Ph.D.
Co-Founder
Investors
×
×